Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-04-27
DOI
10.1038/srep24913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection of Mice against Shiga Toxin 2 (Stx2)-Associated Damage by Maternal Immunization with a Brucella Lumazine Synthase-Stx2 B Subunit Chimera
- (2014) María Pilar Mejias et al. INFECTION AND IMMUNITY
- Adenovirus Vector Expressing Stx1/Stx2-Neutralizing Agent Protects Piglets Infected with Escherichia coli O157:H7 against Fatal Systemic Intoxication
- (2014) Abhineet S. Sheoran et al. INFECTION AND IMMUNITY
- A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice
- (2014) Zhiyong Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice
- (2014) Romina Jimena Fernandez-Brando et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein
- (2014) Jean Mukherjee et al. PLoS One
- A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2
- (2013) Jacqueline M. Tremblay et al. INFECTION AND IMMUNITY
- Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin
- (2013) David J. Vance et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunization with a Chimera Consisting of the B Subunit of Shiga Toxin Type 2 and Brucella Lumazine Synthase Confers Total Protection against Shiga Toxins in Mice
- (2013) M. P. Mejias et al. JOURNAL OF IMMUNOLOGY
- Shiga toxin-producing Escherichia coli O157 : H7 shows an increased pathogenicity in mice after the passage through the gastrointestinal tract of the same host
- (2012) R. J. Fernandez-Brando et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model
- (2012) Jean Mukherjee et al. PLoS One
- Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coli
- (2012) Susanne Hauswaldt et al. Current Infectious Disease Reports
- Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods
- (2011) Romina J. Fernández-Brando et al. PLoS One
- Paradoxical glomerular filtration of carbon nanotubes
- (2010) A. Ruggiero et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli
- (2009) E. L. Lopez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
- (2009) M. Bitzan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding Agents
- (2009) J. Sepulveda et al. INFECTION AND IMMUNITY
- Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producingEscherichia colistrains
- (2008) R. J. F. Brando et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT
- (2008) L. O. T. Gainkam et al. JOURNAL OF NUCLEAR MEDICINE
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now